Technical Analysis for ARAY - Accuray Incorporated
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| 20 DMA Support | Bullish | -3.30% | |
| Crossed Above 50 DMA | Bullish | -3.30% | |
| MACD Bullish Centerline Cross | Bullish | -3.30% | |
| Pocket Pivot | Bullish Swing Setup | -3.30% | |
| 50 DMA Resistance | Bearish | -1.68% | |
| 20 DMA Support | Bullish | -1.68% | |
| Crossed Above 20 DMA | Bullish | -1.68% | |
| Stochastic Reached Oversold | Weakness | -1.68% |
| Alert | Time |
|---|---|
| Down 3% | about 6 hours ago |
| Fell Below 50 DMA | about 6 hours ago |
| Fell Below Previous Day's Low | about 6 hours ago |
| Down 2 % | about 6 hours ago |
| Down 1% | about 6 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/07/2024
Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors in the body. It offers CyberKnife system, an image-guided robotic radiosurgery system used to deliver radiosurgery for the treatment of solid tumors. This system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure enabling the delivery of radiation with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Solid Tumors Tumor Radiation Radiation Therapy Medical Physics Neurosurgery Radiobiology Radiosurgery Treatment Of A Range Of Cancer Cyberknife
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Solid Tumors Tumor Radiation Radiation Therapy Medical Physics Neurosurgery Radiobiology Radiosurgery Treatment Of A Range Of Cancer Cyberknife
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.299 |
| 52 Week Low | 1.4641 |
| Average Volume | 723,901 |
| 200-Day Moving Average | 2.45 |
| 50-Day Moving Average | 1.78 |
| 20-Day Moving Average | 1.77 |
| 10-Day Moving Average | 1.78 |
| Average True Range | 0.11 |
| RSI (14) | 49.24 |
| ADX | 22.19 |
| +DI | 27.54 |
| -DI | 20.20 |
| Chandelier Exit (Long, 3 ATRs) | 1.63 |
| Chandelier Exit (Short, 3 ATRs) | 1.91 |
| Upper Bollinger Bands | 1.89 |
| Lower Bollinger Band | 1.66 |
| Percent B (%b) | 0.44 |
| BandWidth | 13.19 |
| MACD Line | 0.00 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0066 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.95 | ||||
| Resistance 3 (R3) | 1.96 | 1.90 | 1.92 | ||
| Resistance 2 (R2) | 1.90 | 1.85 | 1.90 | 1.91 | |
| Resistance 1 (R1) | 1.83 | 1.82 | 1.80 | 1.82 | 1.90 |
| Pivot Point | 1.78 | 1.78 | 1.76 | 1.77 | 1.78 |
| Support 1 (S1) | 1.71 | 1.73 | 1.68 | 1.70 | 1.62 |
| Support 2 (S2) | 1.65 | 1.70 | 1.65 | 1.61 | |
| Support 3 (S3) | 1.58 | 1.65 | 1.60 | ||
| Support 4 (S4) | 1.57 |
